Accelerated Biosciences
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3675 Market St Ste 200, Philadelphia, Pe...Website
www.acceleratedbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Accelerated Biosciences
Accelerated Biosciences specializes in regenerative medicine, leveraging the unique capabilities of human trophoblast stem cells (hTSCs) to advance therapeutic applications. Their patented hTSC platform provides partners with intellectual property protection and supports the development of innovative medical products. The company aims to reduce development costs and accelerate the time to market for regenerative medicine solutions. They collaborate with biopharma companies and research institutions to enhance the potential of hTSCs in various medical applications.Explore more
Accelerated Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Accelerated Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Accelerated Biosciences recently announced quarterly report
Check out if Accelerated Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Accelerated Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Accelerated Biosciences launches new products
Check if Accelerated Biosciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Accelerated Biosciences
Funding: Get notified immidiatlly once Accelerated Biosciences has new funding data
Click to see if Accelerated Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Accelerated Biosciences
Compare insights from companies similar to Accelerated Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Accelerated Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Accelerated Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Accelerated Biosciences.
Accelerated Biosciences Tech Stack
A closer look at the technologies used by Accelerated Biosciences
See more technologies
Accelerated Biosciences News & Media
Accelerated Bio and Pluristyx create Clinical Grade Induced Pluripotent Stem Cells from Reprogramming Human Trophoblast Stem Cells
PHILADELPHIA--(BUSINESS WIRE)-- #acceleratedbio--Accelerated Biosciences ("Accelerated Bio"), in partnership with Pluristyx, proudly announces the successful creation of clinical grade induced pluripotent stem cell (iPSC) lines using a novel starting material. This groundbreaking achievement utilizes Accelerated Bio’s pre-implantation human trophoblast stem cells (hTSC) as the foundational material. hTSCs are ethically sourced, pre-implantation, low-passage (“young”) cells with unique plasticityAccelerated Biosciences Announces License of its Human Trophoblast Stem Cells (hTSC) to Agathos Biologics for Development of Ethically Sourced Research and Biomanufacturing Platforms
PHILADELPHIA--(BUSINESS WIRE)-- #acceleratedbio--Accelerated Biosciences Corp. (“Accelerated Bio”) is excited to announce a strategic partnership with Agathos Biologics aimed at developing ethically derived cell lines from Accelerated Bio’s human Trophoblast Stem Cells (“hTSC”) for manufacturing complex biologics. This collaboration marks a significant step towards replacing cell lines derived from aborted fetal tissue, including the widely used Human Embryonic Kidney cell line (HEK293), with neAccelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers
HOUSTON, May 16, 2024 /PRNewswire/ -- Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC)...Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing
ALAMEDA, Calif.--(BUSINESS WIRE)--Mekonos, Inc., a biotech platform company building the future of cell engineering on a chip, today announced it has entered into a partnership agreement with Accelerated Biosciences Corp. (“Accelerated Bio”) to codevelop a powerful, new manufacturing cell line based on Accelerated Bio’s human Trophoblast Stem Cells (hTSCs) and Gene Engineered Multi-Sites (GEMS) technology. “We are delighted that Accelerated Bio recognizes the long-term potential of our Mekanofe
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Accelerated Biosciences
Sign Up For FreeTo access detailed company insights
Accelerated Biosciences specializes in regenerative medicine, leveraging the unique capabilities of human trophoblast stem cells (hTSCs) to advance therapeutic applications. Their patented hTSC platform provides partners with intellectual property protection and supports the development of innovative medical products. The company aims to reduce dev... Read More
